Search 

As the first professional injection producer in China,Shanghai Haipu Pharmaceutical factory was founded in 1925 and renamed as Shanghai Xudong Haipu Pharmaceutical Co.,Ltd after jointed with Taiwan Tungyang International Co.,Ltd in 1993.The company has developed for more than 90 years so far, and has accumulated rich experience in production and brand awareness.

致力于CNS领域创新药研发

we are a company focusing on the research and development of new drug

Shenzhen Beimei Pharma is focused in the field of pediatric prescription drugs, and aims to become a new-styled pharmaceutical company integrated with R&D, in-licensing, production and sales. It takes independent R&D and the in-licensing of domestic and international pediatric products as its strategic direction. The current product pipeline covers the respiratory, anti-infection (antibacterial), neuroscience, gastroenterology and others. Beimei Pharma is committed to providing Chinese pediatric patients with convenient, accurate, excellent-taste and high-quality products.

Well renown venture capital firm in China.

China based company with focusing on psychiatry.

Foncoo is a Chiba-based specialty pharma company. We are looking for opportunities in CNS area.

Founded in 2009,Engaged in the R&D，production and sales of peptide related production.

Pregene is a world-leading cell and gene therapy company. Pregene is committed to develop innovative gene and cell therapy technologies and create reliable products from continued innovation and R&D. And pregene can provide CDMO service.

Relying on advantage of the platform resource and industrial agglomeration of dongsheng science and technology park in zhongguancun, ruisheng investment buite the whole chain investment system. Fund manager: shenzhen ruisheng equity investment fund partnership (limited partnership) (registration code: P1034628). To early stage venture fund, incubation fund, late for partial equity investment for the project has a mezzanine fund, stock bonds combined investment, m&a, etc., at the same time, in which foreign involved as an LP covers health, artificial intelligence, new materials, consumption and new energy fields of four professional fund, key node layout industrial chain.